TABLE 3.
Adolescent Sexual Assaults, Relative Risks of Testing, and Prophylaxes Being Offered
| Variable | Testing, RR (95% CI)
|
Prophylaxis, RR (95% CI)
|
||||
|---|---|---|---|---|---|---|
| Pregnancy | Chlamydia-Gonorrheaa | Syphilis | EC (<72 h)b | Chlamydia-Gonorrheaa | HIV PEP (<72 h) | |
| Girls | ||||||
| Testing | ||||||
| Pregnancy | — | 0.97 (0.89–1.04) | 0.73 (0.66–.0.81) | 0.71 (0.63–0.81) | 0.73 (0.66–0.81) | 0.25 (0.19–0.32) |
| Chlamydia-gonorrheaa | 1.04 (0.96–1.12) | — | 0.86 (0.76–0.97) | 0.73 (0.65–0.84) | 0.76 (0.68–0.84) | 0.26 (0.20–0.33) |
| Syphilis | 1.36 (1.23–1.51) | 1.32 (1.19–1.46) | — | 0.97 (0.85–1.12) | 1.00 (0.89–1.13) | 0.34 (0.26–0.44) |
| Prophylaxis | ||||||
| EC (<72 h)b | 1.40 (1.24–1.58) | 1.35 (1.20–1.53) | 1.03 (0.89–1.18) | — | 1.03 (0.89–1.18) | 0.35 (0.27–0.45) |
| Chlamydia-gonorrheaa | 1.36 (1.23–1.51) | 1.31 (1.18–1.46) | 1.00 (0.89–1.13) | 0.97 (0.85–1.12) | — | 0.34 (0.26–0.44) |
| HIV PEP (<72 h) | 4.04 (3.15–5.20) | 3.91 (3.04–5.02) | 2.97 (2.29–3.84) | 2.89 (2.21–3.77) | 2.97 (2.29–3.84) | — |
| Boys | ||||||
| Testing | ||||||
| Chlamydia-gonorrheaa | NA | — | 0.67 (0.23–1.92) | NA | 0.33 (0.08–1.41) | 0.33 (0.05–2.32) |
| Syphilis | NA | 1.5 (0.52–4.32) | — | NA | 0.50 (0.11–2.35) | 0.50 (0.07–3.77) |
| Prophylaxis | ||||||
| Chlamydia-gonorrheaa | NA | 3.0 (0.71–12.69) | 2.0 (0.42–9.42) | NA | — | 1.0 (0.11–9.44) |
| HIV PEP (<72 h) | NA | 3.0 (0.43–20.9) | 2.0 (0.27–15.08) | NA | 1.0 (0.11–9.44) | — |
NA indicates not applicable.
a
Testing or prophylaxis were for either chlamydia and/or gonorrhea.
b
Emergency contraception is also called the “morning after pill” or postcoital contraception.